RiaSTAP New Zealand - English - Medsafe (Medicines Safety Authority)

riastap

csl behring (nz) ltd - fibrinogen 900mg - 1300mg (human) - powder for injection with diluent - 1 g - active: fibrinogen 900mg - 1300mg (human) excipient: albumin arginine hydrochloride sodium chloride sodium citrate water for injection - treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenaemia and hypofibrinogenaemia.

EVICEL FIBRIN SEALANT (HUMAN)- fibrinogen human and thrombin human kit United States - English - NLM (National Library of Medicine)

evicel fibrin sealant (human)- fibrinogen human and thrombin human kit

ethicon inc - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - evicel® fibrin sealant (human) is indicated as an adjunct to hemostasis for use in patients undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical. do not use evicel®: - directly into the circulatory system. intravascular application of evicel® may result in life-threatening thromboembolic events [see warnings and precautions, (5.1) and adverse reactions, (6.2)]. - in individuals known to have anaphylactic or severe systemic reaction to human blood products [see adverse reactions (6.2)]. - for brisk arterial bleeding. - for spraying in endoscopic or laparoscopic procedures in those instances where the minimum recommended distance from the applicator tip to the target site cannot be ensured. [see dosage and administration (2.3)]. risk summary there are no data with evicel® use in pregnant women to inform a drug-associated risk. animal reproduction studies have not been conducted with evicel® . it is not known whether

TISSEEL – Solutions for sealant (2ml vial) Malta - English - Malta Medicines Authority

tisseel – solutions for sealant (2ml vial)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, aprotinin, fibrinogen, human, thrombin - solution for sealant - calcium chloride 40 µmole/ml aprotinin 3000 kiu/ml fibrinogen, human 91 mg/ml thrombin, human 500 iu/mg - antihemorrhagics

TISSEEL – Solutions for sealant (4ml vial) Malta - English - Malta Medicines Authority

tisseel – solutions for sealant (4ml vial)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - human fibrinogen, aprotinin, human thrombin, calcium chloride, dihydrate - solution for sealant - human fibrinogen 182 mg aprotinin 6000 kiu/ml human thrombin 1000 iu calcium chloride dihydrate 80 µmol - antihemorrhagics

TISSEEL – Solutions for sealant (10ml vial) Malta - English - Malta Medicines Authority

tisseel – solutions for sealant (10ml vial)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - human fibrinogen, aprotinin, human thrombin, calcium chloride, dihydrate - solution for sealant - human fibrinogen 455 mg aprotinin 1500 kiu/ml human thrombin 2500 iu calcium chloride dihydrate 200 mmol - antihemorrhagics

VeraSeal solutions for sealant 2 mL (Human fibrinogen 80 mg/mL syringe 1 mL / Human thrombin 500 IU/mL syringe 1 mL) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 2 ml (human fibrinogen 80 mg/ml syringe 1 ml / human thrombin 500 iu/ml syringe 1 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 10 mL (Human fibrinogen 80 mg/mL syringe 5 ml / Human thrombin 500 IU/mL syringe 5 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 10 ml (human fibrinogen 80 mg/ml syringe 5 ml / human thrombin 500 iu/ml syringe 5 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 4 mL (Human fibrinogen 80 mg/mL syringe 2 ml / Human thrombin 500 IU/mL syringe 2 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 4 ml (human fibrinogen 80 mg/ml syringe 2 ml / human thrombin 500 iu/ml syringe 2 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 6 mL (Human fibrinogen 80 mg/mL syringe 3 ml / Human thrombin 500 IU/mL syringe 3 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 6 ml (human fibrinogen 80 mg/ml syringe 3 ml / human thrombin 500 iu/ml syringe 3 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

Tachosil New Zealand - English - Medsafe (Medicines Safety Authority)

tachosil

research associates ltd - fibrinogen 5.5 mg/cm²; thrombin 2 iu/cm² - medicated sponge - 2.0iu/5.5mg per cm² - active: fibrinogen 5.5 mg/cm² thrombin 2 iu/cm² excipient: albumin arginine hydrochloride collagen riboflavin sodium chloride sodium citrate - tachosil is indicated as an adjunct to haemostasis during surgery when control of bleeding by standard surgical techniques is ineffective or impractical.